Former hedge fund manager and pharmaceutical executive, Martin Shkreli, doubled down on his bearish stance against Opendoor Technologies Inc. (NASDAQ: OPEN), drawing parallels with another retail favorite stock that has since witnessed a pullback.
Martin Shkreli Doubles Down On Opendoor ‘Short’ Call: ‘Pharma-Bro’ Draws Parallels With Newegg — ‘Game Over Losers’
